OpGen’s Subsidiary Curetis Receives Batch of Ten New C-Series Unyvero A30 Instruments
22 juin 2023 07h30 HE
|
OpGen, Inc.
Following final assembly and successful testing, a batch of ten Unyvero A30 instrument systems has been receivedLatest C-Series Unyvero A30 instruments optimized for series production and clinical...
Spexis announces the publication of promising results for a novel class of macrocyclic, peptidomimetic antibiotics in Science Advances demonstrating potent in vitro and in vivo antimicrobial activity against MDR and XDR Enterobacteriaceae, including carbapenem-resistant and colistin-resistant strains
07 juin 2023 01h15 HE
|
Spexis AG
ALLSCHWIL, Switzerland, June 06, 2023 (GLOBE NEWSWIRE) -- Spexis AG (SIX: SPEX), a clinical-stage biopharmaceutical company focused on rare diseases and oncology, today announced the publication of...
Antibiotics Global Market Report 2023: Significant Growth Potential of Cell Wall and Protein Inhibitor Drugs Bodes Well for Sector
23 mai 2023 04h18 HE
|
Research and Markets
Dublin, May 23, 2023 (GLOBE NEWSWIRE) -- The "Antibiotics: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering. The global market for antibiotics was...
OpGen Reports First Quarter 2023 Financial Results and Provides Business Update
15 mai 2023 16h15 HE
|
OpGen, Inc.
Total revenue for the first quarter of 2023 was approximately $0.91 million, an increase of approximately 94% compared to the first quarter of 2022Expanded U.S. growth opportunities with the Unyvero...
World Antimicrobial Resistance Diagnostic Market Research Report 2023-2027: From Multiple Pathogens to All Pathogens - The Next Next Generation
18 avr. 2023 03h53 HE
|
Research and Markets
Dublin, April 18, 2023 (GLOBE NEWSWIRE) -- The "Antimicrobial Resistance Diagnostic Markets, Strategies and Trends by Pathogen and Technology, With Executive Guides and Customization 2023 to 2027"...
OpGen’s Subsidiary Curetis Meets Milestones in Collaborative Research Project with InfectoGnostics
03 avr. 2023 07h30 HE
|
OpGen, Inc.
PREPLEX project is part of broader InfectoGnostics Research Campus in Jena, GermanyTotal project volume of PREPLEX collaborative research is approximately $ 0.9 Mio ROCKVILLE, Md., April 03, 2023 ...
North America Antimicrobial Resistance Diagnostics Market Research Report 2022-2028: Industry Developments, Competitive Landscape, Partnerships and Collaborations, & Product Launches and Expansions
10 mars 2023 07h08 HE
|
Research and Markets
Dublin, March 10, 2023 (GLOBE NEWSWIRE) -- The "North America Antimicrobial Resistance Diagnostics Market Size, Share & Industry Trends Analysis Report By Technology, By End User (Hospitals,...
Global Active Pharmaceutical Ingredient Market Report to 2027: Emerging Biosimilars Market and Highly Potent Active Pharmaceutical Ingredients Present Opportunities
28 févr. 2023 12h48 HE
|
Research and Markets
Dublin, Feb. 28, 2023 (GLOBE NEWSWIRE) -- The "Global Active Pharmaceutical Ingredient Market by Type (Innovative, Generic), Manufacturer (Captive, Merchant), Synthesis (Synthetic, Biotech), Product...
Healthcare Industry Veteran Jamie Condie Joins Selux Diagnostics' Board of Directors
14 févr. 2023 07h30 HE
|
Selux Diagnostics
BOSTON, Feb. 14, 2023 (GLOBE NEWSWIRE) -- Selux Diagnostics, a biotech startup in Boston whose mission is to combat superbug infections and antimicrobial resistance (AMR), announced today that...
Global Antimicrobial Resistance Diagnostic Market Analysis Report 2023: Strategies and Trends by Pathogen and Technology with Executive Guides and 5 Year Forecasts
26 janv. 2023 06h28 HE
|
Research and Markets
Dublin, Jan. 26, 2023 (GLOBE NEWSWIRE) -- The "Antimicrobial Resistance Diagnostic Markets, Strategies and Trends by Pathogen and Technology, with Executive Guides and Customization" report has been...